REPORT ID 1641

Asia-Pacific Transdermal Drug Delivery System Market Report 2017

Publish Date
06-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the Asia-Pacific Transdermal Drug Delivery System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Transdermal Drug Delivery System for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Transdermal Drug Delivery System market competition by top manufacturers/players, with Transdermal Drug Delivery System sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Hisamitsu
    Mylan
    GSK
    Novartis
    Teve (Actavis)
    Johnson & Johnson
    Lohmann
    Teikoku Seiyaku
    Bayer
    Lingrui
    Sanofi
    Qizheng
    Endo
    Huarun 999
    Haw Par
    Nichiban
    Mentholatum Company
    Laboratoires Genevrier

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Fentanyl
    Nitroglycerin
    Estradiol
    Nicotine
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    OTC
    Rx

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Transdermal Drug Delivery System Market Report 2017
1 Transdermal Drug Delivery System Overview
    1.1 Product Overview and Scope of Transdermal Drug Delivery System
    1.2 Classification of Transdermal Drug Delivery System by Product Category
        1.2.1 Asia-Pacific Transdermal Drug Delivery System Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Transdermal Drug Delivery System Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Fentanyl
        1.2.4 Nitroglycerin
        1.2.5 Estradiol
        1.2.6 Nicotine
        1.2.7 Other
    1.3 Asia-Pacific Transdermal Drug Delivery System Market by Application/End Users
        1.3.1 Asia-Pacific Transdermal Drug Delivery System Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 OTC
        1.3.3 Rx
    1.4 Asia-Pacific Transdermal Drug Delivery System Market by Region
        1.4.1 Asia-Pacific Transdermal Drug Delivery System Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Transdermal Drug Delivery System (2012-2022)
        1.5.1 Asia-Pacific Transdermal Drug Delivery System Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Transdermal Drug Delivery System Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Transdermal Drug Delivery System Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Transdermal Drug Delivery System Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Transdermal Drug Delivery System (Volume and Value) by Type
        2.2.1 Asia-Pacific Transdermal Drug Delivery System Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Transdermal Drug Delivery System (Volume) by Application
    2.4 Asia-Pacific Transdermal Drug Delivery System (Volume and Value) by Region
        2.4.1 Asia-Pacific Transdermal Drug Delivery System Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Market Share by Region (2012-2017)

3 China Transdermal Drug Delivery System (Volume, Value and Sales Price)
    3.1 China Transdermal Drug Delivery System Sales and Value (2012-2017)
        3.1.1 China Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        3.1.3 China Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    3.2 China Transdermal Drug Delivery System Sales Volume and Market Share by Type
    3.3 China Transdermal Drug Delivery System Sales Volume and Market Share by Application

4 Japan Transdermal Drug Delivery System (Volume, Value and Sales Price)
    4.1 Japan Transdermal Drug Delivery System Sales and Value (2012-2017)
        4.1.1 Japan Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    4.2 Japan Transdermal Drug Delivery System Sales Volume and Market Share by Type
    4.3 Japan Transdermal Drug Delivery System Sales Volume and Market Share by Application

5 South Korea Transdermal Drug Delivery System (Volume, Value and Sales Price)
    5.1 South Korea Transdermal Drug Delivery System Sales and Value (2012-2017)
        5.1.1 South Korea Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    5.2 South Korea Transdermal Drug Delivery System Sales Volume and Market Share by Type
    5.3 South Korea Transdermal Drug Delivery System Sales Volume and Market Share by Application

6 Taiwan Transdermal Drug Delivery System (Volume, Value and Sales Price)
    6.1 Taiwan Transdermal Drug Delivery System Sales and Value (2012-2017)
        6.1.1 Taiwan Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    6.2 Taiwan Transdermal Drug Delivery System Sales Volume and Market Share by Type
    6.3 Taiwan Transdermal Drug Delivery System Sales Volume and Market Share by Application

7 India Transdermal Drug Delivery System (Volume, Value and Sales Price)
    7.1 India Transdermal Drug Delivery System Sales and Value (2012-2017)
        7.1.1 India Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        7.1.3 India Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    7.2 India Transdermal Drug Delivery System Sales Volume and Market Share by Type
    7.3 India Transdermal Drug Delivery System Sales Volume and Market Share by Application

8 Southeast Asia Transdermal Drug Delivery System (Volume, Value and Sales Price)
    8.1 Southeast Asia Transdermal Drug Delivery System Sales and Value (2012-2017)
        8.1.1 Southeast Asia Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    8.2 Southeast Asia Transdermal Drug Delivery System Sales Volume and Market Share by Type
    8.3 Southeast Asia Transdermal Drug Delivery System Sales Volume and Market Share by Application

9 Australia Transdermal Drug Delivery System (Volume, Value and Sales Price)
    9.1 Australia Transdermal Drug Delivery System Sales and Value (2012-2017)
        9.1.1 Australia Transdermal Drug Delivery System Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Transdermal Drug Delivery System Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Transdermal Drug Delivery System Sales Price Trend (2012-2017)
    9.2 Australia Transdermal Drug Delivery System Sales Volume and Market Share by Type
    9.3 Australia Transdermal Drug Delivery System Sales Volume and Market Share by Application

10 Asia-Pacific Transdermal Drug Delivery System Players/Suppliers Profiles and Sales Data
    10.1 Hisamitsu
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Mylan
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Mylan Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 GSK
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 GSK Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Novartis
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Novartis Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Teve (Actavis)
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Johnson & Johnson
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Lohmann
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Lohmann Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Teikoku Seiyaku
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Bayer
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Bayer Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Lingrui
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Transdermal Drug Delivery System Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Lingrui Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Sanofi
    10.12 Qizheng
    10.13 Endo
    10.14 Huarun 999
    10.15 Haw Par
    10.16 Nichiban
    10.17 Mentholatum Company
    10.18 Laboratoires Genevrier

11 Transdermal Drug Delivery System Manufacturing Cost Analysis
    11.1 Transdermal Drug Delivery System Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Transdermal Drug Delivery System Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Transdermal Drug Delivery System Market Forecast (2017-2022)
    15.1 Asia-Pacific Transdermal Drug Delivery System Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Transdermal Drug Delivery System Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Transdermal Drug Delivery System Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Transdermal Drug Delivery System Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Transdermal Drug Delivery System Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Transdermal Drug Delivery System Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Transdermal Drug Delivery System Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Transdermal Drug Delivery System Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Transdermal Drug Delivery System Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Transdermal Drug Delivery System Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Transdermal Drug Delivery System Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Transd